Cape Town Oncology Trials Pty Ltd

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Melanoma2 trials
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Incyte Corporation2 trials
• EMD Serono Research & Development Institute, Inc.1 trial
• IO Biotech1 trial

Running trials

• Active, not recruiting

  IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

  NCT05155254· Phase 3· IO Biotech· Source

Closed trials

• Terminated

  A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

  NCT05879822· Phase 2· Incyte Corporation· Source

• Completed

  Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

  NCT04205812· Phase 3· Incyte Corporation· Source

• Completed

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· Phase 3· EMD Serono Research & Development Institute, Inc.· Source